ArticleHawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health2014
Mid-ventricular variant takotsubo cardiomyopathy associated with Cannabinoid Hyperemesis Syndrome: a case report.
Article in Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 38 citations in OpenAlex.
- Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.Neurogastroenterology and motility · 2019Pooled it
- What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review.Current atherosclerosis reports · 2017Pooled it
- Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2017Pooled it
- Ventricular-Arterial Coupling in Takotsubo Syndrome: Controversies and Opportunities.Journal of cardiovascular development and disease · 2026Article
- Unraveling the Enigma of Cannabinoid Hyperemesis Syndrome: A Narrative Review of Diagnosis and Management.Cureus · 2025Review
- An Individuality of Response to Cannabinoids: Challenges in Safety and Efficacy of Cannabis Products.Molecules (Basel, Switzerland) · 2023Review
- Cannabis Use and Heart Transplantation: Disparities and Opportunities to Improve Outcomes.Circulation. Heart failure · 2022Review
- The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases.Pharmaceuticals (Basel, Switzerland) · 2021Review
- Review
- Cannabis-induced basal-mid-left ventricular stress cardiomyopathy: A case report.International journal of critical illness and injury science · 2020Article
- Congestive Heart Failure Hospitalizations and Cannabis Use Disorder (2010-2014): National Trends and Outcomes.Cureus · 2020Article
- The Impact of Marijuana on the Cardiovascular System: A Review of the Most Common Cardiovascular Events Associated with Marijuana Use.Journal of clinical medicine · 2020Review
- Will Mary Jane Leave You Heartbroken? Marijuana Use and Risk of Takotsubo Cardiomyopathy.Cureus · 2019Article
- Cannabis Use as a Risk Factor for Takotsubo (Stress) Cardiomyopathy: Exploring the Evidence from Brain-Heart Link.Current cardiology reports · 2019Review
- Cannabinoid Hyperemesis.Medical cannabis and cannabinoids · 2019Review
- Cardiovascular Complications of Marijuana and Related Substances: A Review.Cardiology and therapy · 2018Review
- Article
- Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.Nature reviews. Cardiology · 2018Review
- Coronary vasospasm complicating cannabinoid hyperemesis syndrome.Journal of cardiology cases · 2017Article
- Cannabinoid hyperemesis syndrome.BMJ case reports · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A case of the mid-ventricular variant of takotsubo cardiomyopathy is reported, occurring in a patient with Cannabinoid Hyperemesis Syndrome (CHS), and presented with a review of the relevant literature. The patient is a 32-year-old woman who presented with epigastric pain, nausea and vomiting. Her EKG showed dynamic T-wave changes associated with a modest cardiac biomarker elevation. Ventricular wall motion abnormalities suggestive of the mid-ventricular variant of takotsubo cardiomyopathy were demonstrated by echocardiography, ventriculography and cardiac angiography, the latter showing normal coronary arteries. The patient was a previous marijuana user who had recently ingested marijuana after a period of abstinence. Severe epigastric pain, nausea and cyclic vomiting followed this. She had previously experienced similar gastrointestinal symptoms, relieved by compulsive hot water bathing, and resolving after marijuana cessation. Recent resumption of marijuana use was followed by a recurrence of these symptoms, a pattern characteristic of CHS. The association of cardiomyopathy with CHS has been described only once in the literature, and if this is a true relationship, its mechanism is not clearly defined. Animal models have suggested that endocannabinoid receptors are expressed in the myocardium, which could be a pathway for developing cardiac manifestations with cannabinoid use.
Indexed as
Identifiers
24765560PMC3998230W1586572328What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.